Skip to content

Efficacy of Platelet Rich Stroma as an addition to the surgical treatment of Crohn’s perianal fistulas

Efficacy of Platelet Rich Stroma as an addition to the surgical treatment of Crohn’s perianal fistulas

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON26497
Enrollment
40
Registered
2020-03-02
Start date
2018-11-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn's disease

Interventions

None listed

Sponsors

None
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with Crohn’s perianal fistulas, defined as one or more perianal fistula tracts in patients with previously endoscopic or histologic confirmed Crohn’s disease.

Exclusion criteria

Exclusion criteria: • Presence of pelvic sepsis or abscesses at the time of study entry. • Perianal fistula is a rectovaginal fistula. • Any oncological event in the patients history in the previous five years. • Any other medical condition that in the judgement of the investigator could interfere with their optimal participation in the study or produce a significant risk to the patient.

Design outcomes

Primary

MeasureTime frame
Clinical closure combined with radiographic closure of the fistula tract after surgical intervention at 6 months. Clinical closure of fistula tract is defined as closure of the external openings at physical examination. Radiographic closure is defined as the amount of percent decrease in luminal activity measured by hyper intensity on pelvic T2-weighted MRI.

Secondary

MeasureTime frame
• Surgical data • Length of stay in the hospital • Postoperative complications (infection / bleeding) of the perianal and liposuction sites • Time to clinical healing. Clinical healing will be defined as closure of the internal and external opening at physical examination • Need of re-intervention and/or readmissions within 6 months follow up (depending on available time to follow-up)

Contacts

Public ContactJeanine Arkenbosch

Erasmus MC

j.arkenbosch@erasmusmc.nl06-50033976

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)